Skip to main content
Plastic and Reconstructive Surgery Global Open logoLink to Plastic and Reconstructive Surgery Global Open
. 2020 Dec 15;9(1):e3228. doi: 10.1097/GOX.0000000000003228

Telemedicine in the Wake of the COVID-19 Pandemic: Increasing Access to Surgical Care

Paige K Dekker *, Priya Bhardwaj , Tanvee Singh , Jenna C Bekeny , Kevin G Kim *, John S Steinberg , Karen K Evans *, David H Song *, Christopher E Attinger *, Kenneth L Fan *,§,
PMCID: PMC7858711  PMID: 33564566

Background:

The COVID-19 pandemic has brought seismic shifts in healthcare delivery. The objective of this study was to examine the impact of telemedicine in the disadvantaged population.

Methods:

All consecutive patients with outpatient appointments amongst 5 providers in the Plastic and Reconstructive Surgery Department between March 2, 2020, and April 10, 2020, were retrospectively reviewed. Appointment and patient characteristics collected include visit modality, reason for visit, new or established patient, history of recorded procedure, age, sex, race, insurance provider, urban/rural designation of residence, Social Vulnerability Index, and income. The primary outcome of interest was whether or not a patient missed their appointment (show versus no-show).

Results:

During the study period, there were a total of 784 patient appointments. Before the COVID-19 pandemic, patients with a higher Social Vulnerability Index were more likely to have a no-show appointment (0.49 versus 0.39, P = 0.007). Multivariate regression modeling showed that every 0.1 increase in Social Vulnerability Index results in 1.32 greater odds of loss to follow-up (P = 0.045). These associations no longer held true after the lockdown.

Conclusions:

This study indicates a reduction in disparity and an increase in access following the dramatically increased use of telemedicine in the wake of the COVID-19 pandemic. Although drawbacks to telemedicine exist and remain to be addressed, the vast majority of literature points to an overwhelming benefit—both for patient experience and outcomes—of utilizing telemedicine. Future studies should focus on improving access, reducing technological barriers, and policy reform to improve the spread of telemedicine.

INTRODUCTION

The COVID-19 pandemic has resulted in unparalleled shifts and strain in care delivery. Outside of natural disasters, implementation of telehealth and telemedicine has progressed at a slow and fragmented pace.1 Growth in usage between 2005 and 2017 was focused primarily amongst psychiatrists and primary care physicians and utilized by younger patients in urban environments.2 In an effort to curtail the spread of COVID-19, governments and the medical community have responded with a broad shift away from hospital-based care, with cancelled elective surgery and rapid deployment of telemedicine. To mitigate concerns of privacy violations and to broaden use, on March 17, 2020, the Office of Civil Rights at the Department of Health and Human Services issued a statement waiving potential penalties against healthcare providers for Health Insurance Portability and Accountability Act (HIPAA) violations.3 In particular, clear language states that these penalty waivers will apply to “widely available communication platforms, such as FaceTime or Skype, when used in good faith for any telehealth treatment or diagnostic period, regardless of whether the telehealth service is directly related to COVID-19.”

As the pandemic evolved, it also became apparent that a disproportionate number of cases have affected the elderly, men, and those with comorbidities such as hypertension, diabetes, obesity, cardiovascular disease, and minority populations,47 mirroring the H1N1 experience in 2009.8,9 Although there is a need to limit exposure, reconstruction patients (particularly those with active wounds) require a frequent follow-up to prevent wound recurrence and amputation. Delays in such follow-ups lead to prolonged healing times and increased risk of amputation.10,11 Furthermore, several studies have identified worse disease presentation and higher rates of amputation in minority and disadvantaged populations.1215 In a systematic review of studies examining barriers in telehealth adoption, Kruse et al identified that the top 3 barriers for patients were age, level of education, and computer literacy.16 These underlying challenges, coupled with the rapid deployment of telehealth, call into question the effectiveness of technological modalities in caring for disadvantaged patients.

The strategies to limit contact during the current COVID-19 pandemic may be in place for 18 months or longer until widespread vaccination is seen.17 Therefore, it is necessary to ensure equitable distribution of resources and attention to the vulnerable. The objective of this study was to examine how the acute expansion of telemedicine during the COVID-19 pandemic may have impacted access to surgical care in the disadvantaged population. In particular, we sought to investigate whether patient demographics were associated with missed in-person appointments. Special attention was given to the Social Vulnerability Index (SVI), which was created and is maintained by the Geospatial Research, Analysis, and Services Program (GRASP) at the Center for Disease Control and Prevention (CDC). We hypothesize that in the wake of the COVID-19 pandemic, the rapid deployment of telemedicine enhanced access to surgical care for more vulnerable populations.

METHODS

All consecutive patients with outpatient appointments among 5 providers in the Plastic and Reconstructive Surgery Department between March 2, 2020, and April 10, 2020, were retrospectively reviewed. These providers were selected as (1) the 5 highest volume providers and (2) those with the highest percentage of patient visits at our hospital-based practice and not at affiliate hospitals or off-site outpatient clinics. In the District of Columbia, a public emergency was announced on March 11, 2020, and stay-at-home orders were enforced beginning on April 1, 2020. Our system began a multi-phase expansion of its telemedicine platform beginning on March 23, 2020. This date served as an anchor for data collection to capture patients seen by our service before and after the expansion of telemedicine in our system. Patient groups were primarily wound care, general reconstruction, and breast reconstruction.

Data Collection

Data on the following domains were collected from the electronic health record. Appointment characteristics included visit modality (in-person, phone appointment, and video appointment), reason for visit, new or established patient, and history of recorded procedure. Patient characteristics included demographics such as age, sex, race, insurance provider, urban/rural designation of the location of residence, SVI, and median income by location of residence. The primary outcome of interest was whether or not patients missed their appointment (show versus no-show).

For city/suburb/town/rural designation and median income by area of residence, Zone Improvement Program (ZIP) Codes were converted to Zip Code Tabulation Areas (ZCTA), as used by the Census Bureau. ZIP codes are designed to represent linear mail delivery routes, whereas ZCTAs represent more generalized spatial codes that are assigned by census block. For locality designation, the National Center for Education Statistics 2019 data were utilized.18 For median income by ZCTA, the S1901 table from the American Community Survey in 2019 was obtained.19

The overall SVI is derived from census tract-level data, which account for increased granularity of neighborhoods. This is especially important, given the heterogeneous nature of communities in the District of Columbia and its surrounding areas. Census tracts were obtained from the Federal Financial Institutions Examination Council geocoding system, which is used by financial institutions to report information on mortgages as well as business and farm loans.19,20 For addresses that were developed after the census was performed, census tract information was extrapolated based on the longitude and latitude of the address derived from the Google Maps API.

The SVI refers to the socioeconomic and demographic characteristics of a community that impact its resilience when faced with external stressors to human health, including disease outbreaks. The SVI ranks census tracts based on 15 social factors, grouped into 4 themes (Socioeconomic Status, Household Composition and Disability, Minority Status and Language, and Housing Type and Transportation), for an overall SVI score.21 For this study, the overall SVI score was used. A pre-published study suggests that the SVI is associated with higher COVID-19 case fatality.22

Definitions and Exclusion Criteria

Patients from outside the District of Columbia, Maryland, and Virginia regions were eliminated from analysis. A “no-show” was defined as any appointment that a patient did not attend and was both (1) not intentionally rescheduled before the appointment date and (2) the patient was not hospitalized other reasons. Insurances were categorized as commercial (HMO/PPO), Medicaid, or Medicare. Self-pay and other insurances were excluded due to small numbers. Ethnicity was categorized as White, Black, or Other due to the low representation of American Indians, Asians, and Pacific Islanders in our region.23

Statistical Analysis

The statistical analysis was broadly separated into pre-lockdown and post-lockdown to determine the differences between no-show characteristics. Continuous variables were described by means and SDs. The student t-test was used to examine statistically significant differences between continuous variables when normality assumption was satisfied; the Wilcoxon rank sum test was used when normality assumption was not satisfied. Categorical variables were described by frequencies and percentages. Chi-square and Fisher exact tests (n < 10) were used as appropriate to examine statistically significant differences between categorical variables. To test for spatial autocorrelation and clustering of no-show appointments, Moran’s I test for autocorrelation was used.24,25 Two multivariate models before and after the COVID-19 lockdown were constructed with variables selected based on the purposeful selection method, as described by Hosmer and Lemeshow.2628 Multicollinearity was tested to assess the effects of certain variables on others within each model.29 Statistical analysis was performed using STATA, v.15 (StataCorp, College Station, Tex.), with significance defined as P < 0.05.

RESULTS

Table 1 describes the characteristics of the study cohort. During the study period, there were 506 patients seen before the lockdown and 278 patients were seen after, which amounts to a 45% decline in overall visits. Before the lockdown, the composition of our patient population was overrepresented by the elderly and Medicare (42.69% versus 8%) and underrepresented by Medicaid (15.02% versus 28%) when compared with the DC area population.23 Moreover, the average median income is higher for the study group compared with that in the DC area ($99,002 versus $82,372). However, racial composition is similar. The majority of the cohort have active wounds. There is no difference in the SVI or median income by ZCTA before and after COVID-19. Video and phone visits went from comprising 0.59% and 0.79% of visits, respectively, to representing 26.26 and 18.35% of visits, whereas outpatient visits declined 43.2% (P < 0.001). New patient visits declined from 23.52% to 9.35% (P < 0.001). There was a decrease in patients seen without a history of surgery from 48.81% to 31.65% (P < 0.001). There were no significant changes in the number of no-show appointments.

Table 1.

Sample Characteristics Pre-COVID and Post-COVID Lockdown

Pre-lockdown Post-lockdown P
No. patients 506 278
Age 59.40 ± 15.67 61.04 ± 14.76 0.154
Gender 0.315
 Men 241 47.63% 122 43.88%
 Women 265 52.37% 156 56.12%
Ethnicity 0.086
 White 210 41.50% 115 41.37%
 Black 231 45.65% 141 50.72%
 Other 65 12.85% 22 7.91%
Insurance type 0.669
 Commercial 214 42.29% 114 41.01%
 Medicaid 76 15.02% 37 13.31%
 Medicare 216 42.69% 127 45.68%
Locality 0.353
 City 232 45.85% 114 41.01%
 Suburb 193 38.14% 111 39.93%
 Rural 81 16.01% 53 19.06%
History of wounds 0.713
 Yes 404 79.84% 225 80.94%
 No 102 20.16% 53 19.06%
SVI 0.40 ± 0.29 0.41 ± 0.29 0.559
Median income by ZCTA $98,881.18 ± $38,228.90 $99,222.17 ± $41,316.30 0.908
Visit type <0.001
 In-person 499 98.62% 154 55.40%
 Video 3 0.59% 73 26.26%
 Phone 4 0.79% 51 18.35%
Patient status <0.001
 New patient 119 23.52% 26 9.35%
 Established patient 387 76.48% 252 90.65%
History of surgery <0.001
 Yes 259 51.19% 190 68.35%
 No 247 48.81% 88 31.65%
No-show 0.544
 Yes 65 12.85% 40 14.39%
 No 441 87.15% 238 85.61%

Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes the highest vulnerability.

Tables 2 and 3 demonstrate characteristics of patients who showed or missed their appointment before and after the lockdown, respectively. Before the lockdown, younger (P = 0.006), male (P = 0.032), and established (P = 0.035) patients with Medicaid (P = 0.027) were more likely to have a no-show appointment. Patients with a higher SVI were also more likely to have a no-show appointment (0.49 versus 0.39, P = 0.007). After the lockdown, neither age, nor sex, nor established status, nor insurance, nor SVI were any longer significant.

Table 2.

Demographic Characteristics of No-show Appointments before Lockdown

Pre-lockdown
No-show Appointment Yes No P
No. patients 65 441
Age 54.38 ± 15.43 60.14 ± 15.58 0.006
Gender 0.032
 Men 39 16.18% 202 83.82%
 Women 26 9.81% 239 90.19%
Ethnicity 0.075
 White 19 9.05% 191 90.95%
 Black 35 15.15% 196 84.85%
 Other 11 16.92% 54 83.08%
Insurance type 0.027
 Commercial 24 11.21% 190 88.79%
 Medicaid 17 22.37% 59 77.63%
 Medicare 24 11.11% 192 88.89%
Locality 0.968
 City 29 12.50% 203 87.50%
 Suburb 25 12.95% 168 87.05%
 Rural 11 13.58% 70 86.42%
SVI 0.49 ± 0.31 0.39 ± 0.28 0.007
Median income by ZCTA $98,920.51 ± $34,886.35 $98,875.39 ± $38,733.93 0.993
Visit type 0.620
 In-person 64 12.83% 435 87.17%
 Video 0 0% 3 100%
 Phone 1 25% 3 75%
Patient status 0.035
 New patients 43 11.11% 344 88.89%
 Established patients 22 18.49% 97 81.51%
History of surgery 0.006
 Yes 23 8.88% 236 91.12%
 No 42 17.00% 205 83.00%
History of wounds 0.174
 Yes 56 13.86% 348 86.14%
 No 9 8.82% 93 91.18%

Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes the highest vulnerability.

Table 3.

Demographic Characteristics of No-show Appointments after Lockdown

Post-lockdown
No-show Appointments Yes No P
No. patients 40 238
Age 63.86 ± 14.11 60.56 ± 14.84 0.192
Gender 0.235
 Men 21 17.21% 101 82.79%
 Women 19 12.18% 137 87.82%
Ethnicity 0.527
 White 14 12.17% 101 87.83%
 Black 24 17.02% 117 82.98%
 Other 2 9.09% 20 90.91%
Insurance type 0.243
 Commercial 12 10.53% 102 89.47%
 Medicaid 5 13.51% 32 86.49%
 Medicare 23 18.11% 104 81.89%
Locality 0.746
 City 18 15.79% 96 84.21%
 Suburb 16 14.41% 95 85.59%
 Rural 6 11.32% 47 88.68%
SVI 0.40 ± 0.31 0.42 ± 0.29 0.780
Median income by ZCTA $101,590.60 ± $45,629.108 $98,824.11 ± $40,637.767 0.696
Visit type 0.050
 In-person 29 18.83% 125 81.17%
 Video 8 10.96% 65 89.04%
 Phone 3 5.88% 48 94.12%
Patient status 0.307
 New patients 2 7.69% 24 92.31%
 Established patients 38 15.08% 214 84.92%
History of surgery 0.111
 Yes 23 12.11% 167 87.89%
 No 17 19.32% 71 80.68%
History of wounds 0.044
 Yes 37 16.44% 188 83.56%
 No 3 5.66% 50 94.34%

Percentages are expressed by columns. Numbers are accompanied with ± 95% SD. An SVI score of “0” denotes the lowest vulnerability and that of “1” denotes the highest vulnerability.

Table 4 examines the SVI characteristics by visit type. Before the lockdown, the SVI of patients with a no-show in-person appointment was 0.50 compared with 0.39 (P = 0.007) for patients who showed for their in-person appointments. There was no difference in SVI after the lockdown between patients who had shown for their appointment and those who did not. Figure 1 demonstrates that the SVI of new patients (0.44 versus 0.45) and established patients (0.39 versus 0.41) increased after the lockdown versus before the lockdown, although this association was not statistically significant (P = 0.382).

Table 4.

SVI by Visit Type before and after Lockdown

Pre-lockdown Post-lockdown
No-Show Yes No P Yes No P
 In-person 0.50 ± 0.30 0.39 ± 0.28 0.007 0.42 ± 0.32 0.41 ± 0.30 0.818
 Video N/A 0.29 ± 0.18 0.37 ± 0.27 0.41 ± 0.29
 Phone 0.17 ± 0 0.46 ± 0.39 0.32 ± 0.28 0.44 ± 0.29

An SVI score of “0” denotes the lowest vulnerability, and that of “1” denotes highest vulnerability.

Values in bold denote significant p-values (P < 0.05).

Fig. 1.

Fig. 1.

Mean SVI for new and established patients, before and after COVID-19 lockdown.

Table 5 reports the findings of the 2 multivariate regression models for no-show appointments before and after lockdown. Before lockdown, every year decrease in age resulted in a 2% increased chance in missing their appointment (OR = 0.98, P = 0.01). Similarly, male patients had a 1.94 increased odds of missing their appointment (P = 0.02). For socially vulnerable patients, every 0.1 increase in SVI results in 1.32 greater odds of loss to follow-up (P = 0.045). These associations no longer held true after the lockdown. In-person appointments were 3.72 times more likely to be a no-show compared with phone appointments (P = 0.039). There was no clustering of no-show appointments before (P = 0.335), after (P = 0.458), or amongst all patients (P = 0.387).

Table 5.

Multivariate Regression Models: Impact of Telemedicine before and after Lockdown on No-show Appointments

Pre-lockdown Post-lockdown
Odds Ratio Confidence Interval P Odds Ratio Confidence Interval P
Age 0.98 0.96, 0.99 0.01 1.02 0.99, 1.04 0.21
Gender
 Men 1.94 1.11, 3.37 0.02 1.34 0.67, 2.69 0.41
 Women Reference Reference
Ethnicity
 White Reference Reference
 Black 1.26 0.64, 2.46 0.50 1.72 0.75, 3.94 0.20
 Other 1.50 0.65, 3.47 0.35 0.85 0.16, 4.33 0.85
Locality
 Urban Reference Reference
 Suburb 1.23 0.67, 2.25 0.51 0.89 0.41, 1.94 0.76
 Rural 1.30 0.59, 2.83 0.51 0.77 0.27, 0.18 0.63
Patient status
 New patient 1.64 0.91, 2.95 0.097 0.50 0.11, 0.32 0.38
 Established  patient Reference Reference
SVI 2.85 1.02, 7.94 0.045 0.59 0.15, 2.38 0.46
Visit type
 In-person N/A 3.72 1.06, 13.0 0.039
 Video 1.86 0.46, 7.54 0.382
 Phone Reference

DISCUSSION

Telemedicine has seen rapid expansion in the wake of the recent pandemic. Telehealth refers to the broad use of health-related digital services, including monitoring wearables or patient education videos.30 Telemedicine refers to remote diagnosis and treatment using digital technology. Before COVID-19, telemedicine’s expansion was curtailed due to several factors relating to reimbursement, licensure, and infrastructure. Medicare narrowly defined applications to select rural populations. Payments under Medicaid were defined by individual state legislation. Only 10 states (Arkansas, Delaware, Georgia, Hawaii, Kentucky, Minnesota, Missouri, New Mexico, Utah, and Virginia) have laws on true payment parity between telemedicine and in-person visits, whereas 16 states have a provision on the payment structure.31,32 When 104 health care organizations were surveyed, 50% of them reported reimbursement as a significant cause of limitation to deployment.30 There were also limitations in cross-state licensure, limiting providers’ ability to utilize telemedicine to conduct visits with patients outside of their own state.33 As a result of these obstacles to licensure and payment, there was little investment in infrastructure by health providers and organizations alike.

On March 6, 2020, Medicare expanded telehealth services as a temporary and emergency effort under 1135 waiver authority and the Coronavirus Preparedness and Response Supplemental Appropriations Act. Telehealth services were previously limited to designated rural areas.34 In these provisions, Medicare telehealth visits for new and established patients are considered the same as in-person visits and are reimbursed at the same rate in all areas of the country for all settings.34 Furthermore, most states have relaxed licensure requirements for physicians with out-of-state licenses who wish to practice telehealth.35

Broadly speaking, the Centers for Medicaid and Medicare Services categorizes virtual services into 3 main types: televisits, virtual check-ins, and e-visits. Medicare televisits involve interactive audio and telecommunication systems with healthcare providers for new and established patients. Virtual check-ins are 5- to 10-minute communications conducted via telephone or other communication modalities (secure text messaging and email). These are scheduled in response to specific patient concerns that are not related to a medical visit within the previous 7 days or do not result in a visit within the following 24 hours. Although virtual check-ins are generally initiated by patients, providers can educate patients on the availability of these services. Similarly, e-visits are communications that are initiated by established patients through an online portal and are intended to save patients’ trips to physician offices.

The rapid expansion of telemedicine has created a natural experiment on access to care in the vulnerable population. Access to care, as defined by Shi and Singh, “can be defined as the ability to obtain needed, affordable, convenient, acceptable, and effective personal health services in a timely manner.”36 Prior examination of the benefits of telemedicine has demonstrated improvements in access to care for rural patients across multiple healthcare specialties.37,38 Recent research also indicates that telemedicine increases access to care for patients with acute illness in socially disadvantaged populations, which more appropriately distributes healthcare resources.39 However, few studies examine the impact of telemedicine in the surgical subspecialties, especially in the face of the national pandemic.

Despite general improvements in healthcare in America, avoidable access issues are pervasive amongst disparate populations.40 In the previous office-based model, patients of higher SVI were more likely to miss their appointments. The results of this study demonstrate that expansion of telemedicine in the COVID-19 pandemic resulted in improved reach of new and established surgical patients. Anecdotally, patients have been very satisfied with the new format. People who were unable to take “off from work” or arrange childcare, or have difficulties in mobility and arranging transportation are now being seen at greater rates. These finding are in line with a study on the CVS MinuteClinics telehealth program.41 In these visits, physician and patients communicate through 2-way audio and video, and diagnoses are made through history and physicals, and via digital audioscopes and otoscopes. Amongst surveyed patients, 94% reported being very satisfied with the experience, with over half citing the absence of waiting time as their primary motivator for use. Similar high levels of satisfaction were achieved in underserved, rural plastic surgery patients in Vermont and New Hampshire.42

Telemedicine has also proved to have benefits on patient outcomes. One study examining utilization of telemedicine by a wound specialist in conjunction with home health nurses found improved rates of healing, faster healing time, decreased number of home health visits, and fewer hospitalizations for wound complications after telehealth implementation.43 A high level of correlation between in-person and photograph evaluation for the diagnosis and treatment of wounds has been confirmed in the literature.44,45 Systematic review indicates telemedicine increases efficiency, decreases cost, and increases access of microsurgical monitoring, burn evaluation, and cleft lip/palate consultations.42,46

Despite the potential benefits in patient experience and outcomes that may be offered by telemedicine, there are also challenges that must be addressed. Although not statistically significant, we have found that elderly patients and those with limited access and understanding of technology still have difficulty accessing our established online portal. Creative solutions, such as use of FaceTime, the patient’s video conferencing application of choice, or text message, have had to be employed in many instances. It will be critical to establish easy-to-use, HIPAA-compliant technologies to scale. Furthermore, there are limitations in assessing surgical incisions and wounds with current telemedicine platforms. Picture and video quality can be poor, especially if online networks are strained. Patients have to be coached to show the involved body part for context. Commonly, we receive pictures of areas of interest they deem important. This is particularly germane in new patient consults, as a patient–provider relationship is established with transmission of the image.45 The provider assumes legal responsibility, without having met the patient. In the absence of a home health aide, we have to rely on patient’s assessment of warmth, which can be limited. This is particularly salient in the wound population, where decline in warmth can indicate a threatened extremity. Other issues identified in the literature include misdiagnosis, inefficient use of provider time due to technological difficulties, and delays in diagnosis.45

Limitations of this study include the limited number of providers practicing in an urban, academic setting. Our findings may not be generalizable to different localities, including community or rural environments. Furthermore, outcomes such as complications arising from telemedicine use were not directly examined. It is unknown whether the completed telemedicine visits in more vulnerable patients are equitable from a quality perspective. Future study will require an in-depth evaluation of provider and patient factors, barriers to use, reliability of diagnosis and treatments recommended, patient satisfaction, and the workflow of the telemedicine visit, with a focus on elderly and disadvantaged patients.

CONCLUSIONS

Overall, expansion of telemedicine in the COVID-19 era represents a dramatic and, possibly, permanent shift in the way we practice medicine. The results of this study indicate a disparity reduction and increased access in an urban population. The majority of the literature, despite issues with technology and lack of physical contact, cites overwhelming benefits.4147 Future studies should focus on the barriers to use, reliability, patient satisfaction, and workflow in elderly and disadvantaged patients. Sustained meaningful adoption of telemedicine and telehealth will require multi-faceted regulatory flexibility and reform, as seen in the temporary and emergent measures enacted due to the COVID-19 pandemic.48

Footnotes

Published online 22 January 2021.

Disclosure: Dr. Song receives royalties from Elsevier for Plastic Surgery 3e/4e and from Biomet Microfixation for Sternalock. All the other authors have no financial disclosures to declare.

REFERENCES

  • 1.Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. 2020;26:309–313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Barnett ML, Ray KN, Souza J, et al. Trends in telemedicine use in a large commercially insured population, 2005–2017. JAMA. 2018;320:2147–2149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Services OfCRatDoHaH. OCR announces notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency. March 17, 2020. Available at https://www.hhs.gov/about/news/2020/03/17/ocr-announces-notification-of-enforcement-discretion-for-telehealth-remote-communications-during-the-covid-19.html. Accessed May 7, 2020.
  • 4.Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574–1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yancy CW. COVID-19 and African Americans. JAMA. 2020;323:1891–1892. [DOI] [PubMed] [Google Scholar]
  • 6.Milam AJ, Furr-Holden D, Edwards-Johnson J, et al. Are clinicians contributing to excess African American COVID-19 deaths? Unbeknownst to them, they may be. Health Equity. 2020;4:139–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bibbins-Domingo K. This time must be different: disparities during the COVID-19 pandemic. Ann Intern Med. 2020;173:233–234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Quinn SC, Kumar S, Freimuth VS, et al. Racial disparities in exposure, susceptibility, and access to health care in the US H1N1 influenza pandemic. Am J Public Health. 2011;101:285–293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Blumenshine P, Reingold A, Egerter S, et al. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis. 2008;14:709–715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mills JL, Beckett WC, Taylor SM. The diabetic foot: consequences of delayed treatment and referral. South Med J. 1991;84:970–974. [PubMed] [Google Scholar]
  • 11.Smith-Strøm H, Iversen MM, Igland J, et al. Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: a retrospective cohort study. PLoS One. 2017;12:e0177176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lavery LA, Ashry HR, van Houtum W, et al. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care. 1996;19:48–52. [DOI] [PubMed] [Google Scholar]
  • 13.Fan KL, DeLia D, Black CK, et al. Who, what, where: demographics, severity of presentation, and location of treatment drive delivery of diabetic limb reconstructive services within the National Inpatient Sample. Plast Reconstr Surg. 2020;145:1516–1527. [DOI] [PubMed] [Google Scholar]
  • 14.Lavery LA, van Houtum WH, Ashry HR, et al. Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans. South Med J. 1999;92:593–599. [DOI] [PubMed] [Google Scholar]
  • 15.Ashry HR, Lavery LA, Armstrong DG, et al. Cost of diabetes-related amputations in minorities. J Foot Ankle Surg. 1998;37:186–190. [DOI] [PubMed] [Google Scholar]
  • 16.Scott Kruse C, Karem P, Shifflett K, et al. Evaluating barriers to adopting telemedicine worldwide: a systematic review. J Telemed Telecare. 2018;24:4–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Anderson RM, Heesterbeek H, Klinkenberg D, et al. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395:931–934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.U.S. Department of Education. Education Demographic and Geographic Estimates (EDGE) program: ZIP Code Tabulation Area (ZCTA) locale assignments file documentation. Available at https://nces.ed.gov/programs/edge/docs/EDGE_LOCALE_ZCTA_FILEDOC.pdf. Published 2019. Accessed May 7, 2020.
  • 19.United States Census Bureau. Explore Census Data. Available at https://data.census.gov/cedsci/. Published 2020. Accessed May 7, 2020.
  • 20.Federal Financial Institutions Examination Council. Geocoding system. Available at https://geomap.ffiec.gov/FFIECGeocMap/GeocodeMap1.aspx. Published 2020. Accessed May 7, 2020.
  • 21.Agency for Toxic Substances and Disease Registry. CDC’s Social Vulnerability Index. Available at https://svi.cdc.gov/data-and-tools-download.html. Published 2016. Accessed May 7, 2020.
  • 22.Nayak A, Islam SJ, Mehta A, et al. Impact of social vulnerability on COVID-19 incidence and outcomes in the United States. medRxiv. [published online ahead of print April 17, 2020]. [Google Scholar]
  • 23.Kaiser Family Foundation. State health facts. Available at http://www.statehealthfacts.org. Published 2020. Accessed May 7, 2020.
  • 24.Moran PA. Notes on continuous stochastic phenomena. Biometrika. 1950;37:17–23. [PubMed] [Google Scholar]
  • 25.Pisati M. Tools for spatial data analysis. Stata Technical Bulletin. 2001;10. [Google Scholar]
  • 26.Hosmer DW, Lemeshow S. Applied Logistic Regression. 2013Hoboken, NJ: John Wiley & Sons; [Google Scholar]
  • 27.Bursac Z, Gauss CH, Williams DK, et al. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhang Z. Model building strategy for logistic regression: purposeful selection. Ann Transl Med. 2016;4:111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdisciplinary Mathematics. 2010;13:253–267. [Google Scholar]
  • 30.NEJM Catalyst. What is telehealth? Published February 1, 2018. Available at https://catalyst.nejm.org/doi/full/10.1056/CAT.18.0268. Accessed May 13, 2020.
  • 31.Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. N Engl J Med. 2020;382:1679–1681. [DOI] [PubMed] [Google Scholar]
  • 32.Lacktman NM, Acosta JN, Levine SJ. 50-state survey of telehealth commercial payer statues. Available at https://www.foley.com/-/media/files/insights/health-care-law-today/19mc21486-50state-survey-of-telehealth-commercial.pdf. Published December 2019. Accessed May 12, 2020.
  • 33.Weinstein RS, Lopez AM, Joseph BA, et al. Telemedicine, telehealth, and mobile health applications that work: opportunities and barriers. Am J Med. 2014;127:183–187. [DOI] [PubMed] [Google Scholar]
  • 34.Centers for Medicare & Medicaid Services. Medicare telemedicine healthcare provider fact sheet. Available at https://www.cms.gov/newsroom/fact-sheets/medicare-telemedicine-health-care-provider-fact-sheet. Published 2020. Accessed May 12, 2020.
  • 35.Federation of State Medical Boards of the United States. U.S. states and territories modifying requirements for telehealth in response to COVID-19. Available at https://www.fsmb.org/siteassets/advocacy/pdf/states-waiving-licensure-requirements-for-telehealth-in-response-to-covid-19.pdf. Published 2020. Updated May 5, 2020. Accessed May 12, 2020.
  • 36.Shi L, Singh DA. Unequal in access. In: Essentials of the U.S. Health Care System. 2017:Burlington, MA: Jones & Bartlett Learning; 301–302. [Google Scholar]
  • 37.Khairat S, Haithcoat T, Liu S, et al. Advancing health equity and access using telemedicine: a geospatial assessment. J Am Med Inform Assoc. 2019;26:796–805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Marcin JP, Shaikh U, Steinhorn RH. Addressing health disparities in rural communities using telehealth. Pediatr Res. 2016;79:169–176. [DOI] [PubMed] [Google Scholar]
  • 39.Ronis SD, McConnochie KM, Wang H, et al. Urban telemedicine enables equity in access to acute illness care. Telemed J E Health. 2017;23:105–112. [DOI] [PubMed] [Google Scholar]
  • 40.Healey BJ, Evans TM. Health care access. In: Introduction to Health Care Services. 2014:San Francisco, CA: Jossey-Bass; 38–40. [Google Scholar]
  • 41.Polinski JM, Barker T, Gagliano N, et al. Patients’ satisfaction with and preference for telehealth visits. J Gen Intern Med. 2016;31:269–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Funderburk CD, Batulis NS, Zelones JT, et al. Innovations in the plastic surgery care pathway: using telemedicine for clinical efficiency and patient satisfaction. Plast Reconstr Surg. 2019;144:507–516. [DOI] [PubMed] [Google Scholar]
  • 43.Kobza L, Scheurich A. The impact of telemedicine on outcomes of chronic wounds in the home care setting. Ostomy Wound Manage. 2000;46:48–53. [PubMed] [Google Scholar]
  • 44.Wirthlin DJ, Buradagunta S, Edwards RA, et al. Telemedicine in vascular surgery: feasibility of digital imaging for remote management of wounds. J Vasc Surg. 1998;27:1089–1099; discussion 1099. [DOI] [PubMed] [Google Scholar]
  • 45.Murphy RX, Jr, Bain MA, Wasser TE, et al. The reliability of digital imaging in the remote assessment of wounds: defining a standard. Ann Plast Surg. 2006;56:431–436. [DOI] [PubMed] [Google Scholar]
  • 46.Gardiner S, Hartzell TL. Telemedicine and plastic surgery: a review of its applications, limitations and legal pitfalls. J Plast Reconstr Aesthet Surg. 2012;65:e47–e53. [DOI] [PubMed] [Google Scholar]
  • 47.Aziz SR, Ziccardi VB. Telemedicine using smartphones for oral and maxillofacial surgery consultation, communication, and treatment planning. J Oral Maxillofac Surg. 2009;67:2505–2509. [DOI] [PubMed] [Google Scholar]
  • 48.Lee NT, Karsten J, Roberts J.Brookings Institute and The John Locke Foundation. Removing regulatory barriers to telehealth before and after COVID-19. Available at https://www.brookings.edu/research/removing-regulatory-barriers-to-telehealth-before-and-after-covid-19/. Published May 6, 2020. Accessed May 7, 2020.

Articles from Plastic and Reconstructive Surgery Global Open are provided here courtesy of Wolters Kluwer Health

RESOURCES